Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0000950170-24-071493 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-10 | 2024-06-06 | KYTX | Walker Karen Marie | CTO | M - OptEx | $4.42 | +9,636 | 9,636 | New | +$42.6K |
| D | 2024-06-10 | 2024-06-06 | KYTX | Walker Karen Marie | CTO | M - OptEx | $0.00 | -9,636 | 82.6K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | M | A | 9,636 | $4.42 | 9,636 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-06 | M | D | 9,636 | $0.00 | 82,648 | D | $4.42 · — to — | 9,636 Common Stock | (F1) 25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter. |